Hyaluronic Acid Manufacturer

With origins tracing back to a 1984-founded provincial research institute—one of China’s pioneering organizations dedicated to medical-grade hyaluronic acid gel R&D—we have driven technological breakthroughs and industrialization in this field for four decades. Our end-to-end capabilities, spanning from fundamental research to industrial-scale production, are backed by extensive expertise, positioning CIMM as a leader in HA innovation.

Invention patents such as efficient cross-linked HA preparation technology, homogenization technology, unique removal technology of protein false positives, and unique particle size classification technology are applied to them. They exhibit excellent biocompatibility, effectively improving facial tissues, reshaping facial contours, enhancing skin appearance and structure, reducing wrinkles, and preventing skin aging.

Our production adheres to GMP and ISO 13485 standards, using sterile environments and advanced automation to minimize human intervention and ensure safety. Raw materials, approved by the U.S. FDA and European EDAM, meet global quality benchmarks. Manufacturing features advanced impurity removal to reduce BDDE residues to trace levels and non-animal raw materials to lower allergy risk. These deliver proven high safety and quality, trusted worldwide by patients and professionals.

Our innovation ecosystem unites 1 national-level and 4 provincial-level R&D platforms, alongside a team of top-tier talent including Jiangsu Provincial Industrial Professors, Double Creation Talents, postdoctoral researchers, and interdisciplinary expert advisors. Backed by this strength, the company has earned recognition as a National Specialized, Special and New "Little Giant" and Jiangsu Gazelle Enterprise, with a National Postdoctoral Research Station underscoring our innovation authority.